Filing Details

Accession Number:
0001127602-20-026757
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-09 17:12:45
Reporting Period:
2020-10-08
Accepted Time:
2020-10-09 17:12:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1613103 Medtronic Plc MDT () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559405 E Bradley Lerman 710 Medtronic Pkwy Ms Lc300
Minneapolis MN 55432
Svp General Counsel & Corp Sec No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2020-10-08 19,917 $62.76 74,242 No 4 M Direct
Ordinary Shares Disposition 2020-10-08 19,917 $110.00 54,325 No 4 S Direct
Ordinary Shares Acquisiton 2020-10-08 797 $62.76 55,122 No 4 M Direct
Ordinary Shares Disposition 2020-10-08 797 $110.00 54,325 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-10-08 19,917 $0.00 19,917 $62.76
Ordinary Shares Stock Option (Right to Buy) Disposition 2020-10-08 797 $0.00 797 $62.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
19,918 2024-07-28 No 4 M Direct
797 2024-07-28 No 4 M Direct
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This option to purchase 39,835 New Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Merger, was received in the Merger and represents the conversion of 39,835 Medtronic common stock shares for $62.76 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.
  3. This option become exercisable on June 29, 2018, subject to New Medtronic's achievement of a pre-specified cash Earnings Per Share Growth Rate for fiscal years 2016 through 2018."